よむ、つかう、まなぶ。
03【資料１】新型コロナワクチンの接種について (93 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_26922.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会（第33回 7／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考資料一覧（4/7）
武田社ワクチン（ノババックス）に関する諸外国の対応状況
米国
CDC. 2022. CDC Recommends Novavax’s COVID-19 Vaccine for Adults. [online] Available at: <https://www.cdc.gov/media/releases/2022/s0719-covid-novavax-vaccine.html> [Accessed 21 July 2022].
英国
MHRA. 2022. Novavax COVID-19 vaccine Nuvaxovid approved by MHRA. [online] Available at: <https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra>
[Accessed 21 July 2022].
カナダ
NACI. 2022. Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [online] Available at: <https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/nationaladvisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine.pdf> [Accessed 21 July 2022].
フランス
Ministère des Solidarités et de la Santé. 2022. DGS-URGENT. [online] Available at: <https://solidarites-sante.gouv.fr/IMG/pdf/dgs-urgent_2022-35_novavax.pdf> [Accessed 21 July 2022].
ドイツ
Zusammengegencorona.de. 2022. Erster „Totimpfstoff“ gegen COVID-19: Alles Wichtige zu Nuvaxovid® von Novavax. [online] Available at:
<https://www.zusammengegencorona.de/impfen/impfstoffe/erster-totimpfstoff-gegen-covid-19-alles-wichtige-zu-nuvaxovid-r-von-novavax/> [Accessed July 21, 2022].
Robert Koch Institut. 2022. Epidemiologisches Bulletin 7. [online] Available at: <https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/07_22.pdf?__blob=publicationFile> [Accessed 21 July
2022].
イスラエル
Ministry of Health. 2022. ( נחתם הסכם עם חברת נובהווקסNovavax) לרכישת חיסונים נגד קורונה2022. Fourth Vaccine Dose. [online] Available at: <https://www.gov.il/he/departments/news/28012022-01>
[Accessed 21 July 2022].
国際連合
WHO. 2021. WHO lists 10th COVID-19 vaccine for emergency use : Nuvaxovid. [online] Available at: <https://www.who.int/news/item/21-12-2021-who-lists-10th-covid-19-vaccine-for-emergency-usenuvaxovid> [Accessed 21 July 2022].
EU
European Medicines Agency. 2021. EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17. [online] Available at: <https://www.ema.europa.eu/en/news/ema-recommendsauthorisation-nuvaxovid-adolescents-aged-12-17> [Accessed 21 July 2022].
93
93
武田社ワクチン（ノババックス）に関する諸外国の対応状況
米国
CDC. 2022. CDC Recommends Novavax’s COVID-19 Vaccine for Adults. [online] Available at: <https://www.cdc.gov/media/releases/2022/s0719-covid-novavax-vaccine.html> [Accessed 21 July 2022].
英国
MHRA. 2022. Novavax COVID-19 vaccine Nuvaxovid approved by MHRA. [online] Available at: <https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra>
[Accessed 21 July 2022].
カナダ
NACI. 2022. Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [online] Available at: <https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/nationaladvisory-committee-on-immunization-naci/recommendations-use-novavax-nuvaxovid-covid-19-vaccine.pdf> [Accessed 21 July 2022].
フランス
Ministère des Solidarités et de la Santé. 2022. DGS-URGENT. [online] Available at: <https://solidarites-sante.gouv.fr/IMG/pdf/dgs-urgent_2022-35_novavax.pdf> [Accessed 21 July 2022].
ドイツ
Zusammengegencorona.de. 2022. Erster „Totimpfstoff“ gegen COVID-19: Alles Wichtige zu Nuvaxovid® von Novavax. [online] Available at:
<https://www.zusammengegencorona.de/impfen/impfstoffe/erster-totimpfstoff-gegen-covid-19-alles-wichtige-zu-nuvaxovid-r-von-novavax/> [Accessed July 21, 2022].
Robert Koch Institut. 2022. Epidemiologisches Bulletin 7. [online] Available at: <https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/07_22.pdf?__blob=publicationFile> [Accessed 21 July
2022].
イスラエル
Ministry of Health. 2022. ( נחתם הסכם עם חברת נובהווקסNovavax) לרכישת חיסונים נגד קורונה2022. Fourth Vaccine Dose. [online] Available at: <https://www.gov.il/he/departments/news/28012022-01>
[Accessed 21 July 2022].
国際連合
WHO. 2021. WHO lists 10th COVID-19 vaccine for emergency use : Nuvaxovid. [online] Available at: <https://www.who.int/news/item/21-12-2021-who-lists-10th-covid-19-vaccine-for-emergency-usenuvaxovid> [Accessed 21 July 2022].
EU
European Medicines Agency. 2021. EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17. [online] Available at: <https://www.ema.europa.eu/en/news/ema-recommendsauthorisation-nuvaxovid-adolescents-aged-12-17> [Accessed 21 July 2022].
93
93